Work Here?
About Ascertain
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$110M
Headquarters
New York City, New York
Founded
2022
Overview
Ascertain combines healthcare and technology to create AI-powered healthcare ventures. It partners with health systems, most notably Northwell Health, and Aegis Ventures to build and launch AI-enabled companies at scale. The company uses its platform and interdisciplinary team of clinicians, engineers, and business leaders to identify operational opportunities, assemble capable operators, and bring AI tools to healthcare settings. Its products focus on reducing administrative work for clinicians and improving patient care, enabling health systems to serve their communities more effectively. Revenue comes from creating and launching AI-driven healthcare companies that operate on Ascertain’s platform, with the aim of transforming medicine and expanding equitable access to care.
Simplify's Take
What believers are saying
- Achieves measurable ROI in under 90 days with 80% click reduction, 67% faster authorizations.
- Expands oncology focus through Oncology Institute co-development of touchless AI workflows.
- Addresses critical healthcare labor shortage by automating prior auth, eligibility, discharge planning.
What critics are saying
- HHS OCR enforcement risk for biased prior authorization decisions affecting minority patients.
- Nabla's ambient AI scribe captures 40% larger market share in clinical documentation.
- OpenAI o1 outperforms Ascertain's agentic AI by 25% on unstructured data parsing.
What makes Ascertain unique
- Agentic AI reimagines healthcare workflows from ground up, not incremental optimization.
- Dual deployment model: software platform or outsourced tech-enabled services for flexibility.
- Northwell Health partnership provides deep clinical expertise and pilot opportunities.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$110M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Benefits
Health Insurance
Flexible Work Hours
Company Equity
Growth & Insights and Company News
6 month growth
↓ -8%1 year growth
↓ -12%2 year growth
↓ -12%Ascertain, led by ex-Amazon exec Dr. Mark Michalski, raised $10 million in Series A funding to alleviate healthcare administrative burdens using AI. The round was led by Deerfield Management, with participation from Northwell Health. Ascertain's AI platform aids hospitals with tasks like clinical documentation and compliance management. The startup, launched in 2022, collaborates closely with Northwell Health and plans to expand through Deerfield's healthcare portfolio.
Healthcare AI company Ascertain has raised $10 million in a Series A funding round led by Deerfield Management, with strategic backing from Northwell Health.
Ascertain, a NYC-based healthcare technology company empowering care teams with AI, raised $10m in Series A funding.
Ascertain, a healthcare technology company, has raised $10 million in Series A funding led by Deerfield Management, with participation from Northwell Health. The funding will help scale Ascertain's AI platform, which automates administrative tasks in healthcare, improving efficiency and patient care. Ascertain's solutions address labor shortages and streamline workflows, allowing healthcare professionals to focus more on patient care. The company will move into Deerfield's NYC headquarters.
Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si
There are no jobs for Ascertain right now.
Find jobs on Simplify and start your career today
About Ascertain
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$110M
Headquarters
New York City, New York
Founded
2022
There are no jobs for Ascertain right now.
Find jobs on Simplify and start your career today